Gene · 50674
NEUROG3: neurogenin 3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. NEUROG3: neurogenin 3. Genes, record 50674. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/50674
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9Y4Z2 | Neurogenin-3 | 214 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents51
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| WO 2026048797 A | 2026-03-05 | 30 | Q9Y4Z2 | Espacenet |
| WO 2026023241 A | 2026-01-29 | 1 | Q9Y4Z2 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 55440 | Q9Y4Z2 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 117 | Q9Y4Z2 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 745 | Q9Y4Z2 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15358 | Q9Y4Z2 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 117 | Q9Y4Z2 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 745 | Q9Y4Z2 | Espacenet |
| JP 2025032187 A | 2025-03-11 | 10 | Q9Y4Z2 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15358 | Q9Y4Z2 | Espacenet |
1 to 10 of 51
See all 51 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,158
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | NEUROG3 papers | Newest fiscal year |
|---|---|---|---|
| P30DK020593 | Vanderbilt Diabetes Research Center | 16 | 2025 |
| P30DK036836 | Diabetes Research Center | 14 | 2025 |
| R01DK082590 | Regulation of pancreatic islet cell fate | 14 | 2025 |
| P30DK019525 | University of Pennsylvania Diabetes Research Center | 13 | 2025 |
| P30DK063608 | Columbia Diabetes Research Center | 13 | 2025 |
| P30DK078392 | Digestive Health Center (DHC): Bench to Bedside Research in Pediatric Digestive Disease | 13 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 12 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 11 | 2025 |
| P30DK020595 | Diabetes Research and Training Center | 10 | 2025 |
| R01DK090570 | Defining the role of MafA in islet beta cells | 8 | 2025 |
1 to 10 of 1,158Source NIH's project files
See all 1,158 nih grantsPapers1,878
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IL-22 increases proglucagon-expressing enteroendocrine cells via STAT3 in human iPSC-derived intestinal epithelium. | Endocrinology | 2026 | 42687118 | PubTator, text mining | PubMed |
| Naphthoquinones mediate differentiation of human umbilical cord derived mesenchymal stem cells into insulin producing cells through regulation of Wnt and BMP pathways. | Bioimpacts | 2026 | 42666972 | PubTator, text mining | PubMed |
| INSM1 Regulates Neuroendocrine Plasticity and Tumor Progression in Prostate Cancer. | bioRxiv | 2026 | 42619793 | PubTator, text mining | PubMed |
| Possible Mechanisms Underlying the Effects of Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome. | J Neurogastroenterol Motil | 2026 | 42504661 | PubTator, text mining | PubMed |
| Developmental stage-dependent cellular plasticity governs β-cell reprogramming efficiency in human fibroblasts. | Biochem Biophys Res Commun | 2026 | 42335655 | PubTator, text mining | PubMed |
| Ngn3 Regulates Differentiation Competence of Retinal Progenitor Cells Through Transcriptional and Epigenetic Modification. | Int J Mol Sci | 2026 | 42123429 | PubTator, text mining | PubMed |
| Optimal Protocol for Differentiation of Human Tonsil-Derived Mesenchymal Stem Cells into Pancreatic β-like Cells. | Tissue Eng Regen Med | 2026 | 42018227 | PubTator, text mining | PubMed |
| Epigenetic control of PDX1 and NGN3 by a computationally designed PRC2 inhibitor enforces pancreatic endocrine differentiation from pluripotent stem cells. | Res Sq | 2026 | 41928786 | PubTator, text mining | PubMed |
| Engineering Stem Cells for Islet Replacement Therapy: Recent Advances and Barriers for Clinical Translation. | Cells | 2026 | 41892322 | PubTator, text mining | PubMed |
| Bayesian inference of RNA velocity incorporating timepoints, lineage bifurcations, and count data. | PLoS Comput Biol | 2026 | 41860983 | PubTator, text mining | PubMed |
1 to 10 of 1,878
See all 1,878 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/50674
GET https://conductscience.org/api/genes/v1/50674/patents?page=2